Importance of the multidrug and toxin extrusion MATE/SLC47A family to pharmacokinetics, pharmacodynamics/toxicodynamics and pharmacogenomics

作者: Atsushi Yonezawa , Ken-ichi Inui

DOI: 10.1111/J.1476-5381.2011.01394.X

关键词:

摘要: The renal organic cation transport system mediates the tubular secretion of cationic compounds including drugs, toxins and endogenous metabolites into urine. It consists a membrane potential-dependent transporter at basolateral an H+/organic antiporter brush-border membrane. In 2005, human multidrug toxin extrusion MATE1/SLC47A1 was identified as mammalian homologue bacterial NorM. Thereafter, MATE2-K/SLC47A2 rodent MATE were found. Functional characterization revealed that MATE1 MATE2-K antiporter, mediating drugs in cooperation with OCT2. Recently, substrate specificity, transcription mechanisms, structure, polymorphisms, vivo contributions clinical outcomes on have been investigated intensively. this review, we summarize recent findings discuss importance these transporters to pharmacokinetics, pharmacodynamics/toxicodynamics pharmacogenomics drugs.

参考文章(67)
R Hori, H Maegawa, M Kato, T Katsura, K Inui, Inhibitory effect of diethyl pyrocarbonate on the H+/organic cation antiport system in rat renal brush-border membranes. Journal of Biological Chemistry. ,vol. 264, pp. 12232- 12237 ,(1989) , 10.1016/S0021-9258(18)63846-3
H. Koepsell, B. M. Schmitt, V. Gorboulev, Organic cation transporters. Reviews of Physiology Biochemistry and Pharmacology. ,vol. 150, pp. 36- 90 ,(2003) , 10.1007/S10254-003-0017-X
K Inui, R Hori, T Okano, M Takano, H+ gradient-dependent transport of aminocephalosporins in rat renal brush border membrane vesicles: role of H+/organic cation antiport system. Journal of Pharmacology and Experimental Therapeutics. ,vol. 233, pp. 181- 185 ,(1985)
Xiaohong Zhang, Stephen H. Wright, MATE1 has an external COOH terminus, consistent with a 13-helix topology. American Journal of Physiology-renal Physiology. ,vol. 297, ,(2009) , 10.1152/AJPRENAL.00123.2009
Murray R Muirhead, Andrew A Somogyi, Paul E Rolan, Felix Bochner, Effect of cimetidine on renal and hepatic drug elimination: studies with triamterene. Clinical Pharmacology & Therapeutics. ,vol. 40, pp. 400- 407 ,(1986) , 10.1038/CLPT.1986.197
Tomohiro Terada, Ken-ichi Inui, Physiological and pharmacokinetic roles of H+/organic cation antiporters (MATE/SLC47A) Biochemical Pharmacology. ,vol. 75, pp. 1689- 1696 ,(2008) , 10.1016/J.BCP.2007.12.008
A. Somogyi, A. McLean, B. Heinzow, Cimetidine-procainamide pharmacokinetic interaction in man: Evidence of competition for tubular secretion of basic drugs European Journal of Clinical Pharmacology. ,vol. 25, pp. 339- 345 ,(1983) , 10.1007/BF01037945
B Feng, RS Obach, AH Burstein, DJ Clark, SM de Morais, HM Faessel, Effect of human renal cationic transporter inhibition on the pharmacokinetics of varenicline, a new therapy for smoking cessation: an in vitro-in vivo study. Clinical Pharmacology & Therapeutics. ,vol. 83, pp. 567- 576 ,(2008) , 10.1038/SJ.CLPT.6100405